What does CUSIP 800677106 represent in this 13F holders report?

CUSIP 800677106 is the security identifier for SGMO - SANGAMO THERAPEUTICS, INC - Common Stock used to aggregate holder disclosures.

How many institutions held SGMO - SANGAMO THERAPEUTICS, INC - Common Stock in Q2 2017?

143 institutional investors reported SGMO - SANGAMO THERAPEUTICS, INC - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

CUSIP: 800677106

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 294,683,714
Total 13F shares: 53,038,835
Share change: +11,140,174
Total reported value: $466,764,979
Put/Call ratio: 90%
Price per share: $8.80
Number of holders: 143
Value change: +$100,856,480
Number of buys: 76
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 800677106?
CUSIP 800677106 identifies SGMO - SANGAMO THERAPEUTICS, INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 800677106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SGMO - SANGAMO THERAPEUTICS, INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WASATCH ADVISORS LP	13F	Company	2.4%	7,060,135	$36,713,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	1.9%	5,618,851	$29,217,000	—	31 Mar 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	1.5%	4,530,901	$23,561,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	1%	3,087,650	$16,056,000	—	31 Mar 2017	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1%	3,000,000	$15,600,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	0.55%	1,611,083	$8,378,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.42%	1,231,989	$6,409,000	—	31 Mar 2017	13F
Granahan Investment Management, LLC	13F	Company	0.35%	1,032,859	$5,371,000	—	31 Mar 2017	13F
FIC CAPITAL INC	13F	Company	0.32%	940,909	$4,893,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.31%	903,176	$4,697,000	—	31 Mar 2017	13F
Casdin Capital, LLC	13F	Company	0.29%	850,000	$4,420,000	—	31 Mar 2017	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.28%	837,963	$4,357,000	—	31 Mar 2017	13F
ROYCE & ASSOCIATES LP	13F	Company	0.25%	751,100	$3,906,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	633,964	$3,296,000	—	31 Mar 2017	13F
ALTRINSIC GLOBAL ADVISORS LLC	13F	Company	0.21%	630,000	$3,276,000	—	31 Mar 2017	13F
Cormorant Asset Management, LP	13F	Company	0.2%	600,000	$3,120,000	—	31 Mar 2017	13F
Opaleye Management Inc.	13F	Company	0.2%	581,000	$3,021,000	—	31 Mar 2017	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.17%	499,803	$2,599,000	—	31 Mar 2017	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.13%	390,915	$2,033,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	389,981	$2,027,000	—	31 Mar 2017	13F
CREDIT SUISSE AG/	13F	Company	0.12%	363,256	$1,889,000	—	31 Mar 2017	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.12%	355,167	$1,847,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.11%	333,305	$1,732,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.1%	308,705	$1,605,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.1%	295,770	$1,538,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.1%	280,112	$1,457,000	—	31 Mar 2017	13F
S.c.a. Candriam	13F	Individual	0.09%	270,000	$1,404,000	—	31 Mar 2017	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.09%	268,100	$1,394,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	265,735	$1,382,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	219,491	$1,141,000	—	31 Mar 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.07%	206,704	$1,075,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.06%	180,858	$940,000	—	31 Mar 2017	13F
Iguana Healthcare Management, LLC	13F	Company	0.05%	150,000	$780,000	—	31 Mar 2017	13F
QS Investors, LLC	13F	Company	0.05%	145,236	$755,000	—	31 Mar 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	136,781	$711,000	—	31 Mar 2017	13F
KEYBANK NATIONAL ASSOCIATION/OH	13F	Company	0.05%	135,247	$703,000	—	31 Mar 2017	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.05%	134,622	$700,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.04%	128,764	$670,000	—	31 Mar 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.04%	128,200	$667,000	—	31 Mar 2017	13F
GROUP ONE TRADING LLC	13F	Company	0.04%	115,815	$602,000	—	31 Mar 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	114,300	$594,000	—	31 Mar 2017	13F
Swiss National Bank	13F	Company	0.04%	113,560	$591,000	—	31 Mar 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.04%	111,136	$578,000	—	31 Mar 2017	13F
PDT Partners, LLC	13F	Company	0.04%	107,000	$556,000	—	31 Mar 2017	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.03%	95,287	$496,000	—	31 Mar 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	90,241	$469,000	—	31 Mar 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	86,289	$449,000	—	31 Mar 2017	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	85,082	$442,000	—	31 Mar 2017	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.03%	85,000	$442,000	—	31 Mar 2017	13F
FRANKLIN STREET ADVISORS INC /NC	13F	Company	0.03%	76,500	$398,000	—	31 Mar 2017	13F

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2017

As of 30 Jun 2017, SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,038,835 shares. The largest 10 holders included WASATCH ADVISORS INC, BlackRock Inc., BAKER BROS. ADVISORS LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, EcoR1 Capital, LLC, STATE STREET CORP, FMR LLC, Casdin Capital, LLC, and CITADEL ADVISORS LLC. This page lists 143 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

115

Q2 2017 holders

143

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.